AU3509693A - A recombinant hepatitis C virus polypeptide - Google Patents
A recombinant hepatitis C virus polypeptideInfo
- Publication number
- AU3509693A AU3509693A AU35096/93A AU3509693A AU3509693A AU 3509693 A AU3509693 A AU 3509693A AU 35096/93 A AU35096/93 A AU 35096/93A AU 3509693 A AU3509693 A AU 3509693A AU 3509693 A AU3509693 A AU 3509693A
- Authority
- AU
- Australia
- Prior art keywords
- virus polypeptide
- recombinant hepatitis
- hepatitis
- recombinant
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203803A GB9203803D0 (en) | 1992-02-21 | 1992-02-21 | A recombinant polypeptide |
| GB9203803 | 1992-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3509693A true AU3509693A (en) | 1993-09-13 |
Family
ID=10710857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU35096/93A Abandoned AU3509693A (en) | 1992-02-21 | 1993-02-19 | A recombinant hepatitis C virus polypeptide |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU3509693A (en) |
| GB (1) | GB9203803D0 (en) |
| WO (1) | WO1993017110A2 (en) |
| ZA (1) | ZA931203B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6153378A (en) * | 1992-10-16 | 2000-11-28 | Bionova Corporation | Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus |
| KR100312535B1 (en) * | 1993-04-30 | 2002-06-20 | 성재갑 | Antibody Diagnosis of Hepatitis C Virus Using Mixed Antigens |
| AU8003894A (en) * | 1993-10-29 | 1995-05-22 | Srl Inc. | Antigen peptide compound and immunoassay method |
| AU5924396A (en) * | 1995-05-22 | 1996-12-11 | Bionova Corporation | Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv) |
| WO2003099854A2 (en) | 2002-05-24 | 2003-12-04 | Nps Allelix Corp. | Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| EP1532261B1 (en) | 2002-05-24 | 2010-02-10 | Medtronic, Inc. | Methods and dna constructs for high yield production of polypeptides |
| US7829307B2 (en) | 2003-11-21 | 2010-11-09 | Nps Pharmaceuticals, Inc. | Production of glucagon-like peptide 2 |
| EP1809773B1 (en) | 2004-10-18 | 2014-07-16 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis c infection |
| EP2331125A4 (en) | 2008-09-19 | 2013-03-27 | Globeimmune Inc | Immunotherapy for chronic hepatitis c virus infection |
| US8809344B2 (en) | 2008-10-29 | 2014-08-19 | Apath, Llc | Compounds, compositions, and methods for control of hepatitis C viral infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT400724B (en) * | 1989-12-18 | 1996-03-25 | Wellcome Found | VIRAL POLYPEPTIDE |
| CA2032907C (en) * | 1989-12-22 | 2002-05-14 | Richard R. Lesniewski | Hepatitis c assay |
| JP2733138B2 (en) * | 1990-04-04 | 1998-03-30 | カイロン コーポレイション | Hepatitis C virus (HCV) antigen combinations for use in immunoassays for anti-HCV antibodies |
| CA2047792C (en) * | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
| AT405053B (en) * | 1991-06-10 | 1999-05-25 | Lucky Ltd | HEPATITIS-C DIAGNOSIS AND VACCINE |
-
1992
- 1992-02-21 GB GB929203803A patent/GB9203803D0/en active Pending
-
1993
- 1993-02-19 WO PCT/GB1993/000345 patent/WO1993017110A2/en not_active Ceased
- 1993-02-19 ZA ZA931203A patent/ZA931203B/en unknown
- 1993-02-19 AU AU35096/93A patent/AU3509693A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993017110A2 (en) | 1993-09-02 |
| ZA931203B (en) | 1993-10-04 |
| WO1993017110A3 (en) | 1993-10-14 |
| GB9203803D0 (en) | 1992-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2371692A (en) | Recombinant hepatitis a virus vaccine | |
| AU1628895A (en) | Recombinant virus | |
| GB2245272B (en) | Recombinant virus selection system | |
| AU3119895A (en) | Recombinant virus vectors | |
| AU4450093A (en) | Hepatitis A virus vaccine | |
| HUT58371A (en) | Recombinant virus of marek-disease | |
| AU1648092A (en) | Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins | |
| AU3509693A (en) | A recombinant hepatitis C virus polypeptide | |
| AU2683792A (en) | Peptide based hepatitis c virus immunoassays | |
| AU6299594A (en) | Recombinant fowlpox virus s-fpv-043 and uses thereof | |
| EP0747482A3 (en) | Hepatitis GB virus recombinant proteins and uses thereof | |
| AU5679394A (en) | Hepatitis b virus vaccines | |
| AU3775789A (en) | A method of evaluating recombinant vaccines against immunodeficiency virus | |
| AU6715094A (en) | Recombinant vaccine | |
| EP0710120A4 (en) | Recombinant swinepox virus | |
| AU2370592A (en) | Epitopes of the env protein of the hepatitis c virus | |
| AU4271793A (en) | Novel polypeptide | |
| AU3636193A (en) | Analogous peptides of the internal image of a viral protein | |
| AU4554493A (en) | Interferon receptor binding peptides | |
| AU688259B2 (en) | Hepatitis C virus peptides | |
| AU2347692A (en) | Recombinant viral vaccine | |
| IL89601A0 (en) | Expression vectors containing a recombinant vaccinia virus | |
| AU4490989A (en) | Fowlpox virus promoter | |
| AU648475B1 (en) | A novel genome coding phytolacca antiviral protein and a recombinant expression vector therefor | |
| GB9220010D0 (en) | Recombinant virus |